Using Digital Health Technology to Prevent and Treat Diabetes

KaufmanNeal,; SalahiAyten,

doi:10.1089/dia.2017.2506

Cited by 21 publications

(22 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies frequently report that telemedicine and m-health use in diabetes care result in decreased time spent by physicians on patient visits, decreased time spent by patients to commute and wait for their appointments, and reduced loss of productivity at work for adults with diabetes and their caretakers (Iribarren et al, 2017;Kaufman and Khurana, 2016). Unfortunately, as most telemedicine and m-health programs in the literature are pilot studies, cost analyses of widespread implementation of such programs are sparse (de la Torre-Díez et al, 2015).…”

Section: Cost-effectiveness Of Digital Diabetes Carementioning

confidence: 99%

Patient-Driven Diabetes Care of the Future in the Technology Era

Ashrafzadeh

Hamdy

2019

Cell Metabolism

View full text Add to dashboard Cite

The growing burden of diabetes is fueled by obesity-inducing lifestyle behaviors including high-calorie diets and lack of physical activity. Challenges in access to diabetes specialists and educators, low adherence to medications, and inadequate motivational support for proper disease self-management contribute to poor glycemic control in patients with diabetes. Simultaneously, high patient volumes and low reimbursement rates limit physicians' time spent on lifestyle behavior counseling. These barriers to efficient diabetes care lead to high rates of diabetes-related complications, driving healthcare costs up and reducing the quality of patients' lives. Considering recent advancements in healthcare delivery technologies such as smartphone applications, telemedicine, m-health, device connectivity, machine-learning technology, and artificial intelligence, there is significant opportunity to achieve better efficiency in diabetes care and increase patient involvement in diabetes self-management, which ultimately may put an end to soaring diabetesrelated healthcare expenditures. This review explores the patient-driven diabetes care of the future in the technology era.

show abstract

Section: Cost-effectiveness Of Digital Diabetes Carementioning

confidence: 99%

Patient-Driven Diabetes Care of the Future in the Technology Era

Ashrafzadeh

Hamdy

2019

Cell Metabolism

View full text Add to dashboard Cite

show abstract

“…These technological advances have been harnessed to support lifestyle and pharmacological interventions, as well as medical devices (blood glucose meters, continuous glucose monitoring [CGM] devices, insulin pumps and smart pens) [2][3][4][5]. At the forefront is the burgeoning field of digital health technology, notably digital health apps, for people with or at risk for diabetes, which has proliferated and begun to permeate clinical care, research and health product development [6].…”

Section: Introductionmentioning

confidence: 99%

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Fleming¹,

Petrie

Bergenstal

et al. 2019

Diabetologia

View full text Add to dashboard Cite

Digital health technology, especially digital and health applications ('apps'), have been developing rapidly to help people manage their diabetes. Numerous health-related apps provided on smartphones and other wireless devices are available to support people with diabetes who need to adopt either lifestyle interventions or medication adjustments in response to glucose-monitoring data. However, regulations and guidelines have not caught up with the burgeoning field to standardise how mobile health apps are reviewed and monitored for patient safety and clinical validity. The available evidence on the safety and effectiveness of mobile health apps, especially for diabetes, remains limited. The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have therefore conducted a joint review of the current landscape of available diabetes digital health technology (only stand-alone diabetes apps, as opposed to those that are integral to a regulated medical device, such as insulin pumps, continuous glucose monitoring systems, and automated insulin delivery systems) and practices of regulatory authorities and organisations. We found that, across the USA and Europe, mobile apps intended to manage health and wellness are largely unregulated unless they meet the definition of medical devices for therapeutic and/or diagnostic purposes. International organisations, including the International Medical Device Regulators Forum and WHO, have made strides in classifying different types of digital health technology and integrating digital health technology into the field of medical devices. As the diabetes digital health field continues to develop and become more fully integrated into everyday life, we wish to ensure that it is based on the best evidence for safety and efficacy. As a result, we bring to light several issues that the diabetes community, including regulatory authorities, policymakers, professional organisations, researchers, people with diabetes and healthcare professionals, needs to address to ensure that diabetes health technology can meet its full potential. These issues range from inadequate evidence on app accuracy and clinical validity to lack of training provision, poor interoperability and standardisation, and insufficient data security. We conclude with a series of recommended actions to resolve some of these shortcomings.

show abstract

“…These technological advances have been harnessed to support lifestyle and pharmacological interventions, as well as medical devices (blood glucose meters, continuous glucose monitoring [CGM] devices, insulin pumps, and smart pens) (2)(3)(4)(5). At the forefront is the burgeoning field of digital health technology, notably digital health apps, for people with or at risk for diabetes, which has proliferated and begun to permeate clinical care, research, and health product development (6).…”

mentioning

confidence: 99%

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Fleming¹,

et al. 2019

View full text Add to dashboard Cite

Digital health technology, especially digital and health applications ("apps"), have been developing rapidly to help people manage their diabetes. Numerous health-related apps provided on smartphones and other wireless devices are available to support people with diabetes who need to adopt either lifestyle interventions or medication adjustments in response to glucose-monitoring data. However, regulations and guidelines have not caught up with the burgeoning field to standardize how mobile health apps are reviewed and monitored for patient safety and clinical validity. The available evidence on the safety and effectiveness of mobile health apps, especially for diabetes, remains limited. The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have therefore conducted a joint review of the current landscape of available diabetes digital health technology (only stand-alone diabetes apps, as opposed to those that are integral to a regulated medical device, such as insulin pumps, continuous glucose monitoring systems, and automated insulin delivery systems) and practices of regulatory authorities and organizations. We found that, across the U.S. and Europe, mobile apps intended to manage health and wellness are largely unregulated unless they meet the definition of medical devices for therapeutic and/or diagnostic purposes. International organizations, including the International Medical Device Regulators Forum and the World Health Organization, have made strides in classifying different types of digital health technology and integrating digital health technology into the field of medical devices. As the diabetes digital health field continues to develop and become more fully integrated into everyday life, we wish to ensure that it is based on the best evidence for safety and efficacy. As a result, we bring to light several issues that the diabetes community, including regulatory authorities, policy makers, professional organizations, researchers, people with diabetes, and health care professionals, needs to address to ensure that diabetes health technology can meet its full potential. These issues range from inadequate evidence on app accuracy and clinical validity to lack of training provision, poor interoperability and standardization, and insufficient data security. We conclude with a series of recommended actions to resolve some of these shortcomings.

show abstract

Using Digital Health Technology to Prevent and Treat Diabetes

Abstract: Are patients with diabetes mellitus satisfied with technologies used to assist with diabetes management and coping?: a structured review

Cited by 21 publications

References 15 publications

Patient-Driven Diabetes Care of the Future in the Technology Era

Patient-Driven Diabetes Care of the Future in the Technology Era

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Contact Info

Product

Resources

About